| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |